Molecular basis for higher affinity of SARS-CoV-2 spike RBD for human ACE2 receptor

© 2021 Wiley Periodicals LLC..

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has caused substantially more infections, deaths, and economic disruptions than the 2002-2003 SARS-CoV. The key to understanding SARS-CoV-2's higher infectivity lies partly in its host receptor recognition mechanism. Experiments show that the human angiotensin converting enzyme 2 (ACE2) protein, which serves as the primary receptor for both CoVs, binds to the receptor binding domain (RBD) of CoV-2's spike protein stronger than SARS-CoV's spike RBD. The molecular basis for this difference in binding affinity, however, remains unexplained from X-ray structures. To go beyond insights gained from X-ray structures and investigate the role of thermal fluctuations in structure, we employ all-atom molecular dynamics simulations. Microseconds-long simulations reveal that while CoV and CoV-2 spike-ACE2 interfaces have similar conformational binding modes, CoV-2 spike interacts with ACE2 via a larger combinatorics of polar contacts, and on average, makes 45% more polar contacts. Correlation analysis and thermodynamic calculations indicate that these differences in the density and dynamics of polar contacts arise from differences in spatial arrangements of interfacial residues, and dynamical coupling between interfacial and non-interfacial residues. These results recommend that ongoing efforts to design spike-ACE2 peptide blockers will benefit from incorporating dynamical information as well as allosteric coupling effects.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:89

Enthalten in:

Proteins - 89(2021), 9 vom: 15. Sept., Seite 1134-1144

Sprache:

Englisch

Beteiligte Personen:

Delgado, Julián M [VerfasserIn]
Duro, Nalvi [VerfasserIn]
Rogers, David M [VerfasserIn]
Tkatchenko, Alexandre [VerfasserIn]
Pandit, Sagar A [VerfasserIn]
Varma, Sameer [VerfasserIn]

Links:

Volltext

Themen:

ACE2 protein, human
Allostery
Angiotensin-Converting Enzyme 2
COVID-19
EC 3.4.17.23
Journal Article
Molecular dynamics
Protein dynamics
Protein-protein interactions
Receptors, Virus
Research Support, U.S. Gov't, Non-P.H.S.
SARS-CoV
SARS-CoV-2
Spike Glycoprotein, Coronavirus
Spike protein, SARS-CoV-2
Viral entry

Anmerkungen:

Date Completed 09.08.2021

Date Revised 16.07.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1002/prot.26086

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM324193335